Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases

References

• Adams JD, Wang R, Yang J, Lien EJ. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chinese Medicine 2006; 1: 1–15
   Google Scholar
• An LK, Bu XZ, Wu HQ, Guo XD, Ma L, Gu LQ. Reaction of tanshinones with biogenic amine metabolites in vitro. Tetrahedrom 2002; 58: 10315–10321
   Google Scholar
• Bi HC, Law FC, Zhong GP, Xu CS, Pan Y, Ding L, Chen X, Zhao LZ, Xu Q, Huang M. Study of tanshinone IIA tissue distribution in rat by liquid chromatography-tandem mass spectrometry method. Biomedical Chromatography 2007; 21: 473–479
   PubMed Web of Science ®Google Scholar
• Bu XZ, Huang ZS, Zhang M, Ma L, Xiao GW, Gu LQ. Synthesis of new 1,1-dimethyl-1,2,3,4,-tetrahydrophenanthrene derivatives. Tetrahedrom Letters 2001; 42: 5753–5740
   Google Scholar
• Chang HM, Chen KP, Choang TF, Chow HF, Chui Y, Hon PM, Lau Tan FW, Yang Y, Zhong ZP, Lee M, et al. Structure elucidation and total synthesis of new tanshinones isolated from Salvia miltiorriza Bunge (Danshen). Journal of Organic Chemistry 1990; 55: 3537–3543
   Web of Science ®Google Scholar
• Chang PN, Mao JC, Huang SH, Ning L, Wang ZJ, On T, Duan W, Zhu YZ. Analysis of cardioprotective effects using purified Salvia miltiorrhiza extract on isolated rat hearts. Journal of Pharmacology Science 2006; 101: 245–249
   PubMedGoogle Scholar
• Chen TH, Hsu YT, Chen CH, Kao SH, Lee HM. Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264. 7 cells. Mitochondrion 2007a; 7: 101–105
   PubMed Web of Science ®Google Scholar
• Chen X, Yin OQ, Zuo Z, Chow MS. Pharmacokinetics and modeling of quercetin and metabolites. Pharmacology Research 2005; 22: 892–901
   PubMed Web of Science ®Google Scholar
• Chen X, Zhou ZW, Xue CC, Li XX, Zhou SF. Role of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a major active constituent from the root of Salvia miltiorrhiza Bunge, across the blood–brain barrier. Xenobiotica 2007b; 37: 635–678
   PubMed Web of Science ®Google Scholar
• Cheng TO. Danshen: A popular Chinese cardiac herbal drug. Journal of the American College of Cardiology 2006a; 47: 1498
   PubMed Web of Science ®Google Scholar
• Cheng TO. Danshen: What every cardiologist should know about this Chinese herbal drug. International Journal of Cardiology 2006b; 110: 411–412
   PubMed Web of Science ®Google Scholar
• Choudhury R, Chowrimootoo G, Srai K, Debnam E, Rice-Evans CA. Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. Biochemical and Biophysical Research Communication 1999; 265: 410–415
   PubMed Web of Science ®Google Scholar
• Cummins CL, Salphati L, Reid MJ, Benet LZ. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: Studies using the rat single-pass intestinal perfusion model. Journal of Pharmacology and Experimental Therapy 2003; 305: 306–314
   PubMed Web of Science ®Google Scholar
• Danheiser RL, Casebier DS, Loebach JL. Total synthesis of dan shen diterpenoid quinones. Tetrahedron Letters 1992; 33: 1149–1152
   Web of Science ®Google Scholar
• Don MJ, Shen CC, Syu WJ, Ding YH, Sun CM. Cytotoxic and aromatic constituents from Salvia miltiorrhiza. Phytochemistry 2006; 67: 497–503
   PubMed Web of Science ®Google Scholar
• Eeckhoudt SL, Evrard PA, Verbeeck RK. Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat. Drug Metabolism and Disposition 1997; 25: 428–430
   PubMed Web of Science ®Google Scholar
• Gu M, Zhang G, Su Z, Ouyang F. Identification of major active constituents in the fingerprint of Salvia miltiorrhiza Bunge developed by high-speed counter-current chromatography. Journal of Chromatography A 2004; 1041: 239–243
   PubMed Web of Science ®Google Scholar
• Hao H, Wang G, Cui N, Li J, Xie L, Ding Z. Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion. Planta Medica 2006; 72: 1311–1317
   PubMed Web of Science ®Google Scholar
• Hao H, Wang G, Cui N, Li J, Xie L, Ding Z. Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation. Current Drug Metabolism 2007; 8: 137–149
   PubMed Web of Science ®Google Scholar
• Hasselstrom J, Sawe J. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clinical Pharmacokinetics 1993; 24: 344–354
   PubMed Web of Science ®Google Scholar
• He F, Bi HC, Xie ZY, Zuo Z, Li JK, Li X, Zhao LZ, Chen X, Huang M. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: Application to high-throughput inhibition screening of terpenoids. Rapid Communications in Mass Spectrometry 2007; 21: 635–643
   PubMed Web of Science ®Google Scholar
• Huang KJ, Wang H, Xie WZ, Zhang HS. Investigation of the effect of tanshinone IIA on nitric oxide production in human vascular endothelial cells by fluorescence imaging. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy 2007
   Web of Science ®Google Scholar
• Ichikawa T, Ishida S, Sakiya Y, Sawada Y, Hanano M. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats. Journal of Pharmacology Science 1986; 75: 672–675
   PubMed Web of Science ®Google Scholar
• Imanshahidi M, Hosseinzadeh H. The pharmacological effects of Salvia species on the central nervous system. Phytotherapy Research 2006; 20: 427–437
   PubMed Web of Science ®Google Scholar
• Jang SI, Jeong SI, Kim KJ, Kim HJ, Yu HH, Park R, Kim HM, You YO. Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-alpha, IL-1beta and IL-6 in activated RAW 264.7 cells. Planta Medica 2003; 69: 1057–1059
   PubMed Web of Science ®Google Scholar
• Jang SI, Kim HJ, Kim YJ, Jeong SI, You YO. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264. 7 cells: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. European Journal of Pharmacology 2006; 542: 1–7
   PubMedGoogle Scholar
• Ji XY, Tan BK, Zhu YZ. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacologica Sinica 2000; 21: 1089–1094
   PubMed Web of Science ®Google Scholar
• Jiang B, Yin CH. Study on the bioavailability of silymarin-phosphatidylcholine complex in rabbits. Chinese Journal of Pharmaceuticals 2002; 33: 598–600
   Google Scholar
• Langguth P, Lee KM, Spahn-Langguth H, Amidon GL. Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pH. Biopharmaceutics and Drug Disposition 1994; 15: 719–46
   PubMed Web of Science ®Google Scholar
• Lee J, Li JH, Oya S, Snyder JK. Asymmetric synthesis of tanshindiol A. Journal of Organic Chemistry 1992; 57: 5301–5312
   Web of Science ®Google Scholar
• Lee SY, Choi DY, Woo ER. Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bunge. Archives of Pharmacology Research 2005; 28: 909–913
   PubMed Web of Science ®Google Scholar
• Li J, Zhou S, Huynh H, Chan E. Significant intestinal excretion, one source of variability in pharmacokinetics of COL-3, a chemically modified tetracycline. Pharmacology Research 2005; 22: 397–404
   PubMedGoogle Scholar
• Li P, Wang GJ, Li J, Hao HP, Zheng CN. Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry. Journal of Mass Spectrometry 2006a; 41: 670–684
   PubMedGoogle Scholar
• Li P, Wang GJ, Li J, Hao HP, Zheng CN. Identification of tanshinone IIA metabolites in rat liver microsomes by liquid chromatography-tandem mass spectrometry. Journal of Chromatography A 2006b; 1104: 366–369
   PubMed Web of Science ®Google Scholar
• Li P, Wang GJ, Li J, Hao HP, Zheng CN. Simultaneous determination of tanshinone IIA and its three hydroxylated metabolites by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2006c; 20: 815–822
   PubMed Web of Science ®Google Scholar
• Lipka E, Lee ID, Langguth P, Spahn-Langguth H, Mutschler E, Amidon GL. Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs. Journal of Pharmacokinetics and Biopharmaceutics 1995; 23: 267–86
   PubMedGoogle Scholar
• Liu AH, Li L, Xu M, Lin YH, Guo HZ, Guo DA. Simultaneous quantification of six major phenolic acids in the roots of Salvia miltiorrhiza and four related traditional Chinese medicinal preparations by HPLC-DAD method. Journal of Pharmacology and Biomedical Analysis 2006; 41: 48–56
   PubMed Web of Science ®Google Scholar
• Lu T, Song J, Xie L, Wang GJ, Liu XD. Simultaneous determination of baicalin and wogonoside by HPLC in rat plasma administered with Huangqin Decoction and its pharmacokinetic study. Chinese Traditional Herbal Drugs 2005; 36: 870–873
   Google Scholar
• Ma L, Zhang X, Guo H, Gan Y. Determination of four water-soluble compounds in Salvia miltiorrhiza Bunge by high-performance liquid chromatography with a coulometric electrode array system. Journal of Chromatography B: Analytical, Technological, and Biomedical Life Sciences 2006; 833: 260–263
   PubMed Web of Science ®Google Scholar
• Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of reserratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. Journal of Pharmacology and Experimental Therapy 2002; 302: 369–373
   PubMed Web of Science ®Google Scholar
• Mehvar R, Vuppugalla R. Hepatic disposition of the cytochrome P450 2E1 marker chlorzoxazone and its hydroxylated metabolite in isolated perfused rat livers. Journal of Pharmacology Science 2006; 95: 1414–1424
   PubMed Web of Science ®Google Scholar
• Mirfazaelian A, Mahmoudian M. A simple pharmacokinetics subroutine for modeling double peak phenomenon. Biopharmaceutical Drug Disposition 2006; 27: 119–124
   PubMed Web of Science ®Google Scholar
• Ou WP, Mi SQ, Huang TL, Ye SM. Determination of psoralen by HPLC and its application in pharmacokinetic study. Zhongyao Xinyao Yu Linchuang Yaoli 2000; 11: 107–109
   Google Scholar
• Qiao JP, Hou PL, Li YW, Abliz Z. Determination of tanshinone IIA in rat plasma and the pharmacokinetics by RP-HPLC method. Yao Xue Xue Bao 2003; 38: 368–370
   PubMedGoogle Scholar
• Shanghai Cooperative Group for the Study of Tanshinone IIA. Therapeutic effect of sodium tanshinone IIA sulfonate in patients with coronary heart disease. A double blind study. Shanghai Cooperative Group for the Study of Tanshinone IIA. Journal of Traditional Chinese Medicine 1984; 4: 20–24
   PubMedGoogle Scholar
• Shinkuma D, Hamaguchi T, Yamanaka Y, Mizuno N, Yata N. Influence of bile on the gastrointestinal absorption of phenytoin in rats. Chemistry and Pharmacology Bulletin (Tokyo) 1985; 33: 5023–5027
   PubMed Web of Science ®Google Scholar
• Sze FK, Yeung FF, Wong E, Lau J. Does Danshen improve disability after acute ischaemic stroke?. Acta Neurologica Scandinavica 2005; 111: 118–125
   PubMed Web of Science ®Google Scholar
• Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A, Azuma J. Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochemistry and Pharmacology 2002; 64: 745–749
   PubMed Web of Science ®Google Scholar
• Tang F, Wu X, Wang T, Wang P, Li R, Zhang H, Gao J, Chen S, Bao L, Huang H, Liu P. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascular Pharmacology 2007
   Google Scholar
• Tao YY, Liu CH. Progress of research on mechanism of salvia miltiorrhiza and its chemical ingredients against liver fibrosis. Zhong Xi Yi Jie He Xue Bao 2004; 2: 145–148
   PubMedGoogle Scholar
• The Pharmacopoeia Commission of PRC. Pharmacopoeia of the People's Republic of China version 2005. Beijing Chemical Industry Press, Beijing 2005; 1
   Google Scholar
• Traber MG, Kayden HJ, Green JB, Green MH. Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats. American Journal of Clinical Nutrition 1986; 44: 914–923
   PubMed Web of Science ®Google Scholar
• Wang J, Wang X, Jiang S, Yuan S, Lin P, Zhang J, Lu Y, Wang Q, Xiong Z, Wu Y, et al. Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells. Journal of Neurooncology 2007a; 82: 11–21
   PubMed Web of Science ®Google Scholar
• Wang L, Xiong ZY, Wang G. Systematic assessment on randomized controlled trials for treatment of stable angina pectoris by compound salvia pellet. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24: 500–504
   PubMedGoogle Scholar
• Wang X, Morris-Natschke SL, Lee KH. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Medical Research Review 2007b; 27: 133–148
   PubMed Web of Science ®Google Scholar
• Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J, Wang W. Potential anticancer activity of tanshinone IIA against human breast cancer. International Journal of Cancer 2005; 116: 799–807
   PubMed Web of Science ®Google Scholar
• Wei YJ, Li SL, Li P. Simultaneous determination of seven active components of Fufang Danshen tablet by high performance liquid chromatography. Biomedical Chromatography 2007; 21: 1–9
   PubMed Web of Science ®Google Scholar
• Wu B, Liu M, Zhang S. Dan Shen agents for acute ischaemic stroke. Cochrane Database System Review CD004295 2004
   Google Scholar
• Xia WJ, Yang M, Fok TF, Li K, Chan WY, Ng PC, Ng HK, Chik KW, Wang CC, Gu GJ, et al. Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatric Research 2005; 58: 784–790
   PubMed Web of Science ®Google Scholar
• Yang L, Zou X, Liang Q, Chen H, Feng J, Yan L, Wang Z, Zhou D, Li S, Yao S, Zheng Z. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway. Experimental Molecular Medicine 2007; 39: 65–73
   PubMed Web of Science ®Google Scholar
• Yang LJ, Jeng CJ, Kung HN, Chang CC, Wang AG, Chau GY, Don MJ, Chau YP. Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells. Journal of Biomedical Science 2005; 12: 347–361
   PubMed Web of Science ®Google Scholar
• Yang M, Liu A, Guan S, Sun J, Xu M, Guo D. Characterization of tanshinones in the roots of Salvia miltiorrhiza (Dan-shen) by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2006; 20: 1266–1280
   PubMed Web of Science ®Google Scholar
• Yu XY, Lin SG, Chen X, Zhou ZW, Liang J, Duan W, Chowbay B, Wen JY, Chan E, Cao J, et al. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood–brain barrier. Current Drug Metabolism 2007a; 8: 365–378
   PubMed Web of Science ®Google Scholar
• Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Liu PQ, Duan W, Chowbay B, Wen JY, Li CG, et al. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Current Drug Metabolism 2007b; 8: 325–340
   PubMed Web of Science ®Google Scholar
• Yu XY, Zhou ZW, Lin SG, Chen X, Yu XQ, Liang J, Duan W, Wen JY, Li XT, Zhou SF. Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza. Xenobiotica 2007c; 37: 375–415
   PubMed Web of Science ®Google Scholar
• Zhang HS, Wang SQ. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells. Biochemistry and Pharmacology 2007; 73: 1358–1366
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang M, Guan S, Bi HC, Pan Y, Duan W, Chan SY, Chen X, Hong YH, Bian JS, et al. A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. Journal of Pharmacology and Experimental Therapy 2006; 317: 1285–1294
   PubMed Web of Science ®Google Scholar
• Zhao BL, Jiang W, Zhao Y, Hou JW, Xin WJ. Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochemistry and Molecular Biology International 1996; 38: 1171–1182
   PubMedGoogle Scholar
• Zhou L, Zuo Z, Chow MS. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005; 45: 1345–1359
   PubMed Web of Science ®Google Scholar
• Zhou S, Paxton JW, Tingle MD, Kestell P. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid. Drug Metabolism and Disposition 2000; 28: 1449–1456
   PubMed Web of Science ®Google Scholar
• Zhu Y-P. Chinese materia medica: Chemistry, pharmacology and applications. Harwood, Amsterdam 1998
   Google Scholar